arrow
Y

Yiming Cheng

clinical pharmacology, bristol myers squibb, princeton, new jersey, usa
H指数:10
被引数:576

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrative population pharmacokinetic modeling of two BCMA-targeted and one CD19-targeted CAR-T therapies using full Bayesian inference with a student’s t-based M3 censoring approach for robust handling of outliers and BLQ data

整合两种BCMA靶向和一种CD19靶向CAR-T疗法的整合性群体药代动力学建模,采用基于学生t分布的M3截断方法结合全贝叶斯推断,以稳健处理离群值和BLQ数据。

2025-07-240
PRE
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial
2022-11-0146
PRE